Next meeting and ‘coffee morning’
The next membersâ meeting will be on January 11 when Amar Challapalli from the Bristol Haematology and Oncology Centre will present on Radiotherapy in Prostate Cancer. The Zoom talk will cover the history of and new developments in PCa Radiotherapy. Joining details later. The next Zoom âcoffee morningâ is on December 3 (10-noon). Information by email beforehand. New patients and current members are all welcome. New patients can contact us via Contact us (above) or our Tackle helpline (0800 035 5302). The planned dates for next year’s walks are April 8 (Ashton Court) and Oct 8 (Lansdown).
Dave Prowse dies
Bristolian Dave Prowse (Darth Vader and the Green Cross Code man), who was diagnosed with PCa 11 years ago, has died at the age of 85.
Good news re Oliparb
Oliparb has given new hope to men with incurable PCa, says the Daily Mail in this article.
Thanks from Connie
Constance Shiridzinomwa, a urology research nurse at Southmead, has thanked Prospect for the support she received when she started her Masters degree in 2017. Some members took part in her study. She has published her findings and here is the link to her article.
Free creative writing course: new dates
December 8 deadline. There were not enough âtakersâ for the November creative writing course run by Southmead Hospital social prescribing programme, Arts on Referral, on Zoom. These are run regularly for patients who have experienced cancer or are still on treatment. No experience is necessary; it is about creating time for patients to take part in a safe, supportive group, tap into their creativity, and meet others in a similar situation. The next programme will be on Mondays and the deadline for return of the referral forms (available here) is December 8. A Zoom technical taster for patients is on December 17 at noon and the Zoom programme runs: 10amânoon from January 4 to February 8. Donna Baber, the Arts Programme Manager, can take referrals from patients in Bristol, Bath, S Glos, N Somerset and Glos. She is on 07554 334 828, firstname.lastname@example.org or email@example.com
Name changed and a new look
Prostate Cancer Research Centre has dropped the “Centre” from its title and has a new logo. More here
Help with PCa UK website
Prostate Cancer UK seek PCa patients to help them evaluate how people find their way around their health information on their website. To register interest in helping go to
âNanoparticles kill cancerâ
Scientists have created a âTrojan horseâ that sneaks nanoparticles into cancer cells and causes them to self-destruct. The research is still in its early days, but the new method has already proved to be effective at killing cancer cells in a petri dish and reducing tumour growth in mice. See more
Cancer blood test trialled
A new blood test which might be able to detect 50 cancers is being trialled by the NHS. More here. And two professors have made a discovery that could turn cancer into a treatable disease (Sept â20). See more here. And minscule robots can seek out cancer.cells and destroy them More here
Referrals hit by Covid
Prostate cancer referrals halved since lockdown as thousands of men put off seeing their GP, the Daily Mail reported. 27,000 fewer men have been referred to a specialist with suspected cases compared with the same period last year, according to analysis of official NHS data by Prostate Cancer UK. Urgent GP referrals for PCa have plunged to their lowest level in 10 years due to theÂ impact of Covid-19 (Sept â20). More here
Check your risk in 30 seconds!
An online 30-second risk checker has been launched which men are encouraged to take –Â see here And a Prostate Cancer Research team are using machine learning to develop a new way to classify PCa and separate the âtigersâ from the âpussycatsâ (Sept ’20). More here And a US study demonstrated the highest accuracy to date in recognising and characterising PCa using artificial intelligence (July â20). More here Also a new blood test for PCa is producing 99% accuracy – the best yet. More here And a new 15-minute ‘game-changing’ test is announced here
Abiraterone plea heard; deaths up
NICE appeal: NICE agreed to an appeal by Prostate Cancer UK to reverse its decision to restrict abiraterone for advanced PCa (Jul ’20). See more here. UK deaths from PCa exceeded 12,000 in 2019 for the first time and it overtook breast cancer as the most common cancer (June ’20). See more here. But the UK death rate from this cancer is expected to fall by nearly 10 per cent in 2020. See more here Â And a new type of immune cell which kills most cancers has been discovered. More info hereÂ Screening: An expert explained why finding a suitable method is vital but is difficult. See more here